Patient recovery and opioid use after hysterectomy

To analyze how postoperative opioid use and return to activity varies by surgical approach for hysterectomy. Hysterectomies performed gynecologic indications between January 1, 2018 October 31, 2019 abstracted into a statewide collaborative were linked the State's prescription drug monitoring program. We analyzed two outcomes with respect approach: consumption in morphine milligram equivalents (MME) 30 days after hysterectomy, baseline assessed patient questionnaire. Adjusting comorbidities, preoperative use, (open, laparoscopic vaginal hysterectomy), we used multivariable linear regression model logistic identify factors associated >4 weeks surgery respectively. 2,359 of 9,140 patients registry State program included our study. Postoperative MME (mean, 95% CI) was 54.8 (48.7, 60.8) open, 39.8 (37.1, 42.5) laparoscopic, 33.4 (28.5, 38.3) Lower those >65 years, history non-gynecologic cancer, undergoing hysterectomy who had vs 2018. The probabilities returning activities (95% 64% (59-68%) 43% (40-45%) 53% (47-58%) Readmission surgery, cancer <4 weeks. Laparoscopic are lower more rapid normal activities. These findings support importance considering minimally invasive efforts improve safety outcomes.